Order Article Reprints

Shen C-Y, Lu C-H, Cheng C-F, Li K-J, Kuo Y-M, Wu C-H, Liu C-H, Hsieh S-C, Tsai C-Y, Yu C-L. Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases. Biomedicines. 2024; 12(8):1699. https://doi.org/10.3390/biomedicines12081699

Shen, Chieh-Yu, Cheng-Hsun Lu, Chiao-Feng Cheng, Ko-Jen Li, Yu-Min Kuo, Cheng-Han Wu, Chin-Hsiu Liu, Song-Chou Hsieh, Chang-Youh Tsai, and Chia-Li Yu. 2024. "Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases" Biomedicines 12, no. 8: 1699. https://doi.org/10.3390/biomedicines12081699

Shen, C.-Y., Lu, C.-H., Cheng, C.-F., Li, K.-J., Kuo, Y.-M., Wu, C.-H., Liu, C.-H., Hsieh, S.-C., Tsai, C.-Y., & Yu, C.-L. (2024). Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases. Biomedicines, 12(8), 1699. https://doi.org/10.3390/biomedicines12081699